Maven Securities’s Boston Scientific BSX Stock Holding History

Maven Securities’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-12,412	Closed	-$498K	–	1098
2022 Q2	$463K	Buy	+12,412	New	+$505K	0.01%	606
2021 Q4	–	Sell	-27,467	Closed	-$1.15M	–	856
2021 Q3	$1.19M	Buy	+27,467	New	+$1.22M	0.04%	392
2021 Q2	–	Sell	-2,643	Closed	-$111K	–	1074
2021 Q1	$102K	Sell	2,643 -62,357	-96%	-$2.36M	﹤0.01%	999
2020 Q4	$2.34M	Buy	+65,000	New	+$2.34M	0.23%	107
2020 Q3	–	Sell	-65,700	Closed	-$2.53M	–	618
2020 Q2	$2.31M	Buy	+65,700	New	+$2.37M	0.16%	120

Other funds holding BSX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Maven Securities's BSX Position: Q3 2022 in Review

Maven Securities sold out of Boston Scientific (BSX) in Q3 2022, closing a stake of 12,412 shares — an estimated $498K sold.

Maven Securities first reported a position in BSX in Q2 2020 and held it in 5 quarters. The position peaked at $2.34M in Q4 2020. 864 funds tracked by Wall St. Rank hold BSX as of Q3 2022.

Maven Securities reported no remaining Boston Scientific position as of Q3 2022 after selling out during the quarter.
Maven Securities sold 12,412 Boston Scientific shares in Q3 2022, an estimated $498K.
Maven Securities first reported a position in Boston Scientific in Q2 2020 and held it in 5 quarters.
Maven Securities's Boston Scientific position peaked at $2.34M in Q4 2020.
864 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2022.

Based on Maven Securities's 13F filing for Q3 2022, filed 14 Nov 2022.